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Purpose or Objective: Target position is variable during 
fractionated prostate radiotherapy, mainly due to rectal 
changes. Margin reduction is preferable with the 
advancements of modulated techniques and IGRT. However, 
geometric uncertainty can persist in the absence of an 
intervention to minimise rectal motion. The purpose of this 
study is to retrospectively evaluate the effectiveness of three 
rectal emptying strategies in maintain rectal stability and 
reducing target motion during prostate radiotherapy. 
 
Material and Methods: Four cohorts of consented prostate 
patients (total n=37) underwent different rectal strategies: 
daily phosphate enema; low-fibre diet and microlax 
microenema and no intervention (control). Using 
retrospective CBCT data, (8 CBCTs per patients), inter-
fraction PTV motion relative to bony anatomy was measured 
using automatic bone anatomy registration, followed by an 
automatic Structure Volume of Interest (SVOI) match. 
Changes in rectal diameter (RD) at the base, mid and apex of 
the prostate and rectal volume (RV) were measured using the 
CBCT data. Frequency of prostate geometric miss was 
assessed, with a miss defined as any PTV shift in any 
direction. 
 
Results: PTV displacement was significantly reduced in the 
anteroposterior (AP) direction in the microlax group 
(p=0.004), and in the superoinferior (SI) direction in the 
phosphate enema group (p=0.013) when compared with the 
control group (Table 1). The frequency of geometric miss was 
lowest in the microlax group. RD variability at the base of 
prostate was significantly smaller in the microlax and 
phosphate enema groups compared to the control group 
stats, and variation in RV was smallest in the microlax group. 




Conclusion: Microlax microenema is an effective intervention 
in maintaining rectal stability, and PTV motion during 




Plan of the day approach in post prostatectomy radiation 
therapy 
C. Lac
1Central Coast Cancer Centre, Radiation Oncology, Gosford, 
Australia 
1, A. Sims1, T. Eade1,2, A. Kneebone1,2 
2Northern Sydney Cancer Centre, Radiation Oncology, St 
Leonards, Australia 
 
Purpose or Objective: Our primary aim is to investigate the 
frequency of using smaller margins for post prostatectomy 
radiotherapy (RT) in conjunction with daily soft tissue image 
guided radiotherapy (IGRT). Our secondary aim is to assess 
the feasibility of implementing an adaptive, ‘plan of the 
day’, treatment approach by selecting an appropriate plan on 
a daily basis which will highly conform to the target and 
minimise rectal and bladder toxicities. 
 
Material and Methods: Retrospectively identified 19 post 
prostatectomy patients. Soft tissue matching guidelines were 
created and split into two categories; patients with or 
without surgical clips. Soft tissue match was performed on 
cone-beam CT (CBCT) in offline review program by two 
radiation therapists and reviewed by two radiation 
oncologists. The frequency of geographic miss was measured 
using a planning target volume (PTV) small with a 5 mm 
clinical target volume (CTV) expansion and PTV large with 10 
mm (15 mm anteriorly) CTV expansion. To implement a ‘plan 
of the day’ treatment approach, a post prostatectomy soft 
tissue training module was developed to educate the 
radiation therapists to perform daily soft tissue alignment. 
Radiation therapists will then apply an adaptive RT regime 
that selects from a plan library to account for internal organ 
inconsistencies of the bladder and rectum. 
 
Results: A total of 135 CBCTs were reviewed on 19 radical 
post prostatectomy patients including those with lymph node 
involvement. Retrospective soft tissue match analysis 
determined that PTV small covered the target for 84% of 
CBCTs while the PTV large covered the target for 16%. There 
was no geographic miss outside PTV large in this 
retrospective analysis. In the matches that resulted in the 
selection of PTV large, 12% of CBCTs were due to variations 
in bladder filling and 4% from rectal filling. 
 
Conclusion: PTV small is suitable for use on most CBCTs with 
PTV large selected for only a small portion of CBCTs. Very 
small bladders caused a greater amount of bladder and small 
bowel to fall in the target and increases the chance of side 
effects but rarely causes a geographic miss. Over filling 
bladders on CBCTs was undesired as it caused internal pelvic 
tilt in the superior portion resulting in a selection of the plan 
with PTV large. A dangerous combination is present if there 
are inconsistencies to both the bladder and rectum filling 
causing the CTV prostate bed region to tilt and fall outside of 
the target. With a high frequency of using PTV small, and a 
better understanding of the effect of bowel and bladder 
filling, implementation of ‘plan of the day’ is feasible. This 
will result in a highly targeted treatment delivery in 
conjunction with soft tissue IGRT that will reduce toxicities 
and increase local control. 
 
Poster Viewing : 12: Physics: Dose measurement and dose 




Validation of an optimised MC dose prediction for low 
energy X-rays intraoperative radiation therapy 
P. Ibáñez
1Universidad Complutense de Madrid, Física Atómica- 
Molecular y Nuclear, Madrid, Spain 
1, M. Vidal1, P. Guerra2, J.M. Udías1 
2Universidad Politécnica de Madrid, Ingeniería Electrónica, 
Madrid, Spain 
 
Purpose or Objective: Low energy X-rays Intra-Operative 
Radiation Therapy (XIORT) is increasingly used in oncology, 
predominantly for breast cancer treatments with spherical 
applicators [1], but also for skin or gastrointestinal cancer [2] 
with surface and flat applicators. This study aims to validate 
a fast and precise method [3,4] to calculate Monte Carlo (MC) 
dose distributions with an optimized phase space file (PSF) 
obtained from a previously stored database of 
monochromatic PSF and depth dose curves (DDP) for different 
INTRABEAM® (Carl Zeiss) applicators. To validate this 
procedure, we compared dose computed with the PSF with 
measurements in phantoms designed to prove actual XIORT 
scenarios. 
 
Material and Methods: PSF were optimized from 
experimental DDP in water and were employed to calculate 
dose distributions, first in water, then in validation phantoms 
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such as air gaps or bone inhomogeneities, for all flat, surface 
and spherical applicators. Measurements with Gafchromic 
EBT3 films were performed. Irradiated ﬁlms were scanned 
with an EPSON Expression 10000XL ﬂatbed scanner 
(resolution 72 ppi) after a polymerization time of at least 24 
h, and the three-channel information corrected for 
inhomogeneity [5] was used to derive dose. Calibration films 
were irradiated from 0 Gy to 5 Gy for surface and flat 
applicators and from 0 Gy to 20 Gy for spherical applicators. 
Simulations and experimental data were compared in detail. 
 
Results: MC simulations are in good agreement with 
experimental data, at the 3%-1 mm level (10% dose 
threshold) for most setups, well within what is needed for 
XIORT planning. Accuracy of the comparison was mostly 
limited by the difficulty in assuring geometrical positioning 
within 1 mm or less of the physical phantoms. An example of 
dose distribution on a heterogeneous phantom of PMMA and 
bone for a 3 cm flat applicator is shown in figure 1. 
 
 
Figure 1. Experimental (top) and simulated (bottom) dose 
distributions of a PMMA-bone phantom with a 3 cm diameter 
flat applicator. More than 90% voxels pass the 3%-1mm 
gamma test. 
 
Conclusion: Preliminary results show that the optimized 
Monte Carlo dose calculation reproduces dose distributions 
measured with different applicators, accurately enough for 
XIORT planning. The method is flexible and fast, and has 
been incorporated in Radiance® [6], a treatment planning 
system for intraoperative radiation therapy developed by the 
GMV company. 
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Purpose or Objective: In-beam PET exploits the β+ 
activation induced in the patient's body by the hadron-
therapy (HT) particle beam to perform treatment monitoring 
and dose-delivery accuracy assessment. The INSIDE 
collaboration is building an in-beam PET and tracker 
combined device for HT. In this work we focus on the 
preliminary PET measurements performed at the CNAO 
(Italian Hadron-therapy National Center) synchrotron facility 
and on Monte Carlo simulations. 
 
Material and Methods: The PET module block is made of 
16x16 Lutetium Fine Silicate scintillator elements 3.2x3.2x20 
mm³ each, coupled one-to-one to a Silicon Photomultiplier 
matrix, read out by the TOFPET ASIC. The scanner will 
feature two 10x20 cm2 planar heads, made by 10 modules 
each, at a distance of 25 cm from the iso-centre. Preliminary 
tests investigated the performance of one module per head 
at nominal distance. Monoenergetic proton pencil beams of 
68, 72, 84 MeV and 100 MeV were targeted to a PMMA 
phantom placed inside the FOV of the two detectors. The 
CNAO synchrotron beam has a periodic structure of 1 s beam 
delivery (spill) and 4 s interval (inter-spill). Acquisition was 
performed both in- and inter-spill. A 250 ps coincidence 
window is applied to find the LORs and reconstruct the image 
with a MLEM algorithm. Monte Carlo (MC) simulations are 
used in HT for detector development and treatment planning. 
In case of 3D online monitoring, they could also be used to 
compare the acquired image, which is a measurements of the 
activity, with the expected distribution, and hence to assess 
the treatment accuracy. Taking into account the detection 
and digitisation processes, it is also possible to reconstruct 
the simulated image. MC simulations, performed with FLUKA, 
were used to assess the expected performance and also 
compared to the measured activity profiles. 
 
Results: Acquisition has been successfully performed in both 
inter-spill and in-spill mode. The inter-spill and in-spill 
Coincidence Time Resolution (CTR) between the two 
modules, measured without a fine time calibration, is 459 ps 
and 630 ps σ, respectively. The larger in-spill value is 
expected and related to background uncorrelated events. 
The images profile along the beam axis for the 68 and 72 MeV 
beam energies, which have a range short enough to be 
stopped by the phantom inside the FOV (5x5x5 cm³), show 
the characteristic distal activity fall-off. The expected proton 
range difference in PMMA for 68 and 72 MeV (3.64 mm) is 
compatible with the experimental measurement (3.61±0.10 
mm), obtained by fitting with sigmoid functions the fall-off 




Conclusion: Tests with proton beams and prototype detector 
modules has confirmed the feasibility of the INSIDE in-beam 
PET monitoring device. Simulations are in good agreement 
with data and could be used to calculated the expected 
activity distribution measured by the PET scanner. 
 
 
